Advertisement

PharmacoEconomics & Outcomes News

, Volume 770, Issue 1, pp 21–21 | Cite as

Polypill cost effective for preventing CVD if price reduced

Clinical study

Reference

  1. Ferket BS, et al. Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease. Heart : 11 Jan 2017. Available from: URL: http://doi.org/10.1136/heartjnl-2016-310529

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations